Given that a STAT3 inhibitor with ROS-promoting activity may be a new strategy for the treatment of solid tumors, we hypothesized that these new hybrids of curcumin with a BTP moiety may inhibit STAT3 activation and lead to ROS accumulation and ultimately induce cancer cell apoptosis. This evidence concerns the gene STAT3 and cancer.